Fund Holdings — Column Group LLC

Total Portfolio Value
$71.28M
Total Bought
$815.4K
Total Sold
$28.84M
Net Transaction
-$28.02M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Revolution Medicines Inc(RVMD)46460120.00%0
Sagimet Biosciences Inc.(SGMT)17,16917,169093590.08%-34
Surrozen, Inc.(SRZN)616,540810,088+193,5489,6868,87012.44%-815
RAPT Therapeutics Inc2,680,6212,680,621024,0728,17611.47%-15,896
Tenaya Therapeutics, Inc.(TNYA)9,400,2909,400,290049,16429,14140.88%-20,023
ORIC Pharmaceuticals Inc.(ORIC)3,540,7773,540,777048,68625,03335.12%-23,652
NGM Biopharmaceuticals Inc18,136,7350-18,136,73528,8370—-28,837
Page 1 of 1
Column Group LLC — 13F Holdings — Q2 2024 | TickerTrail